Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Construction in Progress (2012 - 2018)

Updated

Alnylam Pharmaceuticals (ALNY) reported Construction in Progress of $260.98 million for Q4 2018, up 95.3% from $133.65 million a year earlier.

Analysis

Alnylam Pharmaceuticals (ALNY) Construction in Progress (2012 - 2018) Analysis & Trends

Dating back to Q4 2012, Alnylam Pharmaceuticals' Construction in Progress record includes 7 quarters.

  • Construction in Progress has a five-year compound annual growth rate of 522.1% (FY2013 to FY2018).
  • By year, Construction in Progress came in at $133.65 million in FY2017 (+96.0%), $68.18 million in FY2016, $1.29 million in FY2015 (-35.2%) and $1.98 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 260.98 Mn
Dec 31, 2017 133.65 Mn
Dec 31, 2016 68.18 Mn
Dec 31, 2015 1.29 Mn
Dec 31, 2014 1.98 Mn
Dec 31, 2013 28,000.00
Dec 31, 2012 8.21 Mn
API Access

Alnylam Pharmaceuticals Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ALNY&period=max&api_key=YOUR_API_KEY